1000 Coloplast employees to give Atos flying start in China
On Monday, Coloplast announced the acquisition of Atos Medical for DKK 16bn (USD 2.5bn). The plan now is to grow the Swedish company in a number of global markets, says President and CEO at Coloplast Kristian Villumsen, who highlights the two companies' synergies in China, where Atos has multiple upcoming product launches.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
Coloplast's President and CEO Kristian Villumsen eyes global growth opportunities in Atos Medical, which the Danish medtech company has just acquired for DKK 16bn (USD 2.5bn).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast's USD 2.5bn acquisition is its biggest ever
For subscribers
.jpg&w=384&q=75)
